EUVIMEDEUVIMED entdecken
Open Access

Loss of 12-Lipoxygenase Improves the Post-Transfusion Function of Stored Platelets

Hannah J Larsen, Daire Byrne, Tahsin Özpolat iD, Aastha Chauhan, S Lawrence Bailey, Nicole Rhoads iD, Franklin Reed, Massiel C Stolla iD, Reheman Adili iD, Michael Holinstat iD, Xiaoyun Fu, Moritz Stolla iD

Arteriosclerosis, Thrombosis, and Vascular Biology · 2023

DOI: 10.1161/atvbaha.123.319021 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Arteriosclerosis, Thrombosis, and Vascular Biology, 2023. Verfasst von Hannah J Larsen und 11 weiteren Autor:innen. Beteiligte Einrichtung: Bloodworks Northwest Research Institute, Seattle, WA (H.J.L., D.B., T.Ö., A.C., S.L.B., N.R., F.R., R.A., X.F., M.S.). Hauptthemen laut MEDLINE: Arachidonate 12-Lipoxygenase, Blood Platelets. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, NIGMS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Platelets for transfusion are stored for 5 to 7 days. Previous studies have shown that HETE levels in the storage bag negatively correlate with platelet performance in vivo, suggesting that the dysregulation of bioactive lipid mediators may contribute to the storage lesion. In the current study, we sought to understand how genetic deletion and pharmacological inhibition of 12-LOX (12-lipoxygenase) affects platelets during storage and after transfusion. METHODS: Platelets from 12-LOX +/+ (wild-type [WT]) and 12-LOX −/− mice were stored for 24 and 48 hours and profiled using liquid chromatography-tandem mass spectrometry–multiple reaction monitoring or transfused into thrombocytopenic hIL4R (human interleukin 4 receptor)-transgenic mice. Platelet function was assessed by flow cytometry and in vivo thrombosis and hemostasis models. To test the role of the COX-1 (cyclooxygenase-1) pathway, donor mice were treated with acetylsalicylic acid. Human platelets were treated with the 12-LOX inhibitor, VLX-1005, or vehicle, stored, and transfused to NOD/SCID (nonobese diabetic/severe combined immunodeficiency) mice. RESULTS: Polyunsaturated fatty acids increased significantly in stored platelets from 12-LOX −/− mice, whereas oxylipin concentrations were significantly higher in WT platelets. After transfusion to thrombocytopenic mice, we observed significantly more baseline αIIbβ3 integrin activation in 12-LOX −/− platelets than in WT platelets. Stored platelets from 12-LOX −/− mice occluded vessels significantly faster than stored WT platelets. In hemostasis models, significantly more stored 12-LOX −/− than WT platelets accumulated at the site of venous injury leading to reduced blood loss. Inhibition of COX-1 abrogated both increased integrin activation and thromboxane generation in stored 12-LOX −/− platelets, highlighting the critical role of this pathway for improved post-transfusion function. Consistent with our mouse studies, human platelets stored with VLX-1005, showed increased integrin activation compared with vehicle-treated platelets after transfusion. CONCLUSIONS: Deleting 12-LOX improves the post-transfusion function of stored murine platelets by increasing thromboxane generation through COX-1–dependent arachidonic acid metabolism. Future studies should determine the feasibility and safety of 12-LOX–inhibited platelets transfused to humans.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Arachidonate 12-LipoxygenaseBlood PlateletsHumansMiceAnimalsMice, Inbred NODMice, SCIDMice, TransgenicPlatelet Glycoprotein GPIIb-IIIa ComplexThromboxanes

Stichwörter der Autor:innen

arachidonic acidblood plateletshemostasislipoxygenasesmice

Substanzen

Arachidonate 12-LipoxygenasePlatelet Glycoprotein GPIIb-IIIa ComplexThromboxanes

Autor:innen und Institutionen

  • Bloodworks Northwest Research Institute, Seattle, WA (H.J.L., D.B., T.Ö., A.C., S.L.B., N.R., F.R., R.A., X.F., M.S.).
  • Division of Hematology, Department of Medicine (M.C.S., X.F., M.S.), University of Washington Medical Center, Seattle.
  • Department of Pharmacology, University of Michigan, Ann Arbor (M.H.).
  • Department of Laboratory Medicine and Pathology (M.S.), University of Washington Medical Center, Seattle.

ORCID-Profile: Tahsin Özpolat, Nicole Rhoads, Massiel C Stolla, Reheman Adili, Michael Holinstat, Moritz Stolla

Förderung

  • NHLBI NIH HHS
  • NIGMS NIH HHS

Zitieren

APA

Larsen, H. J., Byrne, D., Özpolat, T., Chauhan, A., Bailey, S. L., Rhoads, N., Reed, F., Stolla, M. C., Adili, R., Holinstat, M., Fu, X., & Stolla, M. (2023). Loss of 12-Lipoxygenase Improves the Post-Transfusion Function of Stored Platelets. Arteriosclerosis, Thrombosis, and Vascular Biology. https://doi.org/10.1161/atvbaha.123.319021

Vancouver

Larsen HJ, Byrne D, Özpolat T, Chauhan A, Bailey SL, Rhoads N, et al. Loss of 12-Lipoxygenase Improves the Post-Transfusion Function of Stored Platelets. Arteriosclerosis, Thrombosis, and Vascular Biology. 2023. doi:10.1161/atvbaha.123.319021

BibTeX
@article{Larsen2023,
  author = {Larsen, Hannah J and Byrne, Daire and Özpolat, Tahsin and Chauhan, Aastha and Bailey, S Lawrence and Rhoads, Nicole and Reed, Franklin and Stolla, Massiel C and Adili, Reheman and Holinstat, Michael and Fu, Xiaoyun and Stolla, Moritz},
  title = {Loss of 12-Lipoxygenase Improves the Post-Transfusion Function of Stored Platelets},
  journal = {Arteriosclerosis, Thrombosis, and Vascular Biology},
  year = {2023},
  doi = {10.1161/atvbaha.123.319021}
}
Kostenlos starten →